(Q41880985)

13 October 2017

0 references

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies (English)

1 reference

13 October 2017

B Xu

1

1 reference

13 October 2017

N Tong

2

1 reference

13 October 2017

J-m Li

3

1 reference

13 October 2017

Z-d Zhang

4

1 reference

13 October 2017

H-f Wu

5

1 reference

13 October 2017

16 March 2010

1 reference

Prostate Cancer and Prostatic Diseases

13 October 2017

1 reference

13 October 2017

13

1 reference

13 October 2017

3

1 reference

13 October 2017

270-277

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2010.6

13 October 2017

0 references

cites work

Lifestyle as risk factor for cancer: Evidence from human studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

5 June 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

HPC2/ELAC2 gene variants associated with incident prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Statistical aspects of the analysis of data from retrospective studies of disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Role of HPC2/ELAC2 in hereditary prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

HPC2 variants and screen-detected prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

A candidate prostate cancer susceptibility gene at chromosome 17p

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association of HPC2/ELAC2 genotypes and prostate cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Is dietary fat a risk factor for prostate cancer?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Meta-analysis in clinical trials

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Publication bias in clinical research

5 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

5 June 2018

https://api.crossref.org/works/10.1038%2FPCAN.2010.6

Mendelian inheritance of familial prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922791

Family history of prostate cancer: A multi-center case-control study in Canada

18 August 2018

2 references

https://api.crossref.org/works/10.1038%2FPCAN.2010.6

31 March 2020

https://pubmed.ncbi.nlm.nih.gov/20231859

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.6

HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.6

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.6

Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20231859

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PCAN.2010.6

1 reference

Dimensions Publication ID

13 October 2017

0 references

1 reference

13 October 2017

1 reference